These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 30106443)
1. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2. Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443 [TBL] [Abstract][Full Text] [Related]
2. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer. Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407 [TBL] [Abstract][Full Text] [Related]
3. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer. Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263 [TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075 [TBL] [Abstract][Full Text] [Related]
5. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
6. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells]. Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313 [TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Liu T; Peng H; Zhang M; Deng Y; Wu Z Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353 [TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway. Zhang YZ; Wang CF; Zhang LF Oncol Rep; 2018 Jun; 39(6):2595-2603. PubMed ID: 29658590 [TBL] [Abstract][Full Text] [Related]
10. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells. Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460 [TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882 [TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α. Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213 [TBL] [Abstract][Full Text] [Related]
13. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950 [TBL] [Abstract][Full Text] [Related]
14. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells. Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796 [TBL] [Abstract][Full Text] [Related]
15. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells. Satriyo PB; Su CM; Ong JR; Huang WC; Fong IH; Lin CC; Aryandono T; Haryana SM; Deng L; Huang CC; Tzeng YM; Chao TY; Liu HW; Yeh CT Toxicol Appl Pharmacol; 2021 Jul; 422():115493. PubMed ID: 33727089 [TBL] [Abstract][Full Text] [Related]
16. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Kuo PL; Chen CY; Hsu YL Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211 [TBL] [Abstract][Full Text] [Related]
17. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer. Tan XL; Guo L; Wang GH Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121 [TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B Induces Hypermethylation of Oncogenes in Breast Cancer Cells. Dittharot K; Dakeng S; Suebsakwong P; Suksamrarn A; Patmasiriwat P; Promkan M Planta Med; 2019 Mar; 85(5):370-378. PubMed ID: 30463098 [TBL] [Abstract][Full Text] [Related]
19. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Chen J; Zeng J; Xin M; Huang W; Chen X Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171 [TBL] [Abstract][Full Text] [Related]
20. Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways. Ha YM; Kim MY; Park MK; Lee YS; Kim YM; Kim HJ; Lee JH; Chang KC Apoptosis; 2012 May; 17(5):463-74. PubMed ID: 22183510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]